GLP-1 pills are coming, and they could revolutionize weight-loss
Sep 17, 2024 · Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. But she and other doctors also warn about the potential for misuse, a...
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
June 23, 2024, 5:46 PM UTC. By Berkeley Lovelace Jr. The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo...
FDA clarifies policies for compounders as national GLP-1 supply …
The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
Aug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
The Crackdown on Compounded GLP-1 Meds Has Begun
Oct 10, 2024 · Eli Lilly has sent cease-and-desist letters to hundreds of compounding pharmacies, telehealth companies, and medical spas making and selling “compounded” versions of tirzepatide.
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
1 day ago · 2 min read. Nov. 12, 2024 – Most people taking GLP-1 drugs for weight loss or diabetes no longer need to stop taking them before elective surgery, according to new guidance from the American ...
HRS9531 is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, offering a treatment option for individuals with overweight or obesity, as well as type 2 diabetes. This Phase 2 study evaluated the efficacy and safety of …
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
Oct 30, 2023 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
Evaluating the benefits of the early use of GLP-1 receptor agonists
19 hours ago · Originally developed to improve glycaemic control in patients with type 2 diabetes, GLP-1 receptor agonists have emerged as promising agents for weight management and cardiovascular protection, expanding their therapeutic potential beyond diabetes care.1 Since 2016, clinical trials such as LEADER,2 SELECT,3 and SURPASS4 have demonstrated the cardiovascular benefits of GLP-1 receptor agonists ...
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t
Oct 9, 2024 · Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation.